Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

33.75
-0.7100-2.06%
Post-market: 33.750.00000.00%16:04 EST
Volume:2.25M
Turnover:76.18M
Market Cap:3.90B
PE:-15.92
High:34.56
Open:33.65
Low:33.25
Close:34.46
52wk High:43.15
52wk Low:18.92
Shares:115.55M
Float Shares:110.00M
Volume Ratio:0.77
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1195
EPS(LYR):-3.1920
ROE:-47.34%
ROA:-30.27%
PB:6.10
PE(LYR):-10.57

Loading ...

Lilly, Novo Shares Fall over 2% Each. Novo Nordisk to Cut U.S. List Prices for Ozempic, Wegovy by up to 50%

Dow Jones
·
Yesterday

Viking Therapeutics rises 10.7%

TIPRANKS
·
Yesterday

Unusually active option classes on open February 23rd

TIPRANKS
·
Feb 23

Viking Therapeutics Surges as Obesity Drug Hopes Rise

TIPRANKS
·
Feb 21

Viking Therapeutics Builds Obesity Platform As VK2735 Trials Accelerate

Simply Wall St.
·
Feb 16

Viking Therapeutics Bets Big on Obesity Breakthroughs

TIPRANKS
·
Feb 13

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Feb 13

Viking Therapeutics Stock Soars: What's Driving The Momentum?

Benzinga
·
Feb 13

Jefferies Keeps Their Buy Rating on Viking Therapeutics (VKTX)

TIPRANKS
·
Feb 12

Maxim Group Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)

TIPRANKS
·
Feb 12

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical

Reuters
·
Feb 12

Viking Therapeutics (VKTX) Gets a Buy from Piper Sandler

TIPRANKS
·
Feb 12

BUZZ-U.S. STOCKS ON THE MOVE-Cisco Systems, Viking Therapeutics, Albemarle

Reuters
·
Feb 12

Morgan Stanley Trims Price Target on Viking Therapeutics to $99 From $102, Keeps Overweight Rating

MT Newswires Live
·
Feb 12

Viking Therapeutics Shares up 11.7% Premarket as Co Plans to Advance Oral Obesity Drug to Late-Stage Testing

THOMSON REUTERS
·
Feb 12

Viking Therapeutics Plans To Advance Oral Obesity Drug To Late-Stage Testing

Reuters
·
Feb 12

Stock Track | Viking Therapeutics Soars 12.26% in Pre-Market on Positive Obesity Drug Pipeline Updates

Stock Track
·
Feb 12

Stock Track | Viking Therapeutics Soars 9.91% in Post-Market on Positive Pipeline Updates Despite Earnings Miss

Stock Track
·
Feb 12

Analysts Are Bullish on These Healthcare Stocks: Viking Therapeutics (VKTX), CSL (CMXHF)

TIPRANKS
·
Feb 12

BUZZ-Viking Therapeutics rises on plans to test oral obesity drug in late-stage studies

Reuters
·
Feb 12